NP137
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for NP137, covering 2026-02-05 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies [Phase 2]